Bradykinin potentiates insulin-stimulated glucose uptake and enhances insulin signal through the bradykinin B2 receptor in dog skeletal muscle and rat L6 myoblasts

Department of Metabolic Medicine, Kumamoto University School of Medicine, Honjo, Japan.

Previously we demonstrated that bradykinin infusion could increase glucose uptake into dog peripheral tissues, and that bradykinin could potentiate insulin-induced glucose uptake through glucose transporter 4 (GLUT4) translocation in dog adipocytes. However, skeletal muscle is the predominant tissue for insulin-mediated glucose disposal. The aim of this study was to determine how bradykinin affected insulin-stimulated glucose uptake in dog skeletal muscle and myotubes transformed from rat L6 myoblasts. The bradykinin receptor binding studies revealed that dog skeletal muscle and rat L6 myoblasts possessed significant numbers of bradykinin receptors (Kd = 88 and 76 pmol/l, Bmax = 82.5 and 20 fmol/mg protein respectively). An RT-PCR (reverse transcriptase-polymerase chain reaction) amplification showed mRNA specific for bradykinin B2 receptor in both cells. Bradykinin significantly increased 2-deoxyglucose uptake in isolated muscle and L6 myoblasts in the presence of insulin (10(-7) mol/l) in a dose-dependent manner, but not in the absence of insulin. Bradykinin also enhanced insulin-stimulated GLUT4 translocation, and insulin-induced phosphorylation of insulin receptor beta subunit and insulin receptor substrate-1 (IRS-1) without affecting the binding affinities or numbers of cell surface insulin receptors in both cells. It is concluded that bradykinin could potentiate the insulin-induced glucose uptake through GLUT4 translocation in dog skeletal muscle and rat L6 myoblasts. This effect could be explained by the potency of bradykinin to upregulate the insulin receptor tyrosine kinase activity which stimulates phosphorylation of IRS-1, followed by an increase in GLUT4 translocation.

This article has been cited by other articles:

				F. Respondek, K. S. Swanson, K. R. Belsito, B. M. Vester, A. Wagner, L. Istasse, and M. Diez Short-Chain Fructooligosaccharides Influence Insulin Sensitivity and Gene Expression of Fat Tissue in Obese Dogs J. Nutr., September 1, 2008; 138(9): 1712 - 1718. [Abstract] [Full Text] [PDF]

				E. J. Henriksen Improvement of insulin sensitivity by antagonism of the renin-angiotensin system Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2007; 293(3): R974 - R980. [Abstract] [Full Text] [PDF]

				G. Yuan, J. Deng, T. Wang, C. Zhao, X. Xu, P. Wang, J. W. Voltz, M. L. Edin, X. Xiao, L. Chao, et al. Tissue Kallikrein Reverses Insulin Resistance and Attenuates Nephropathy in Diabetic Rats by Activation of Phosphatidylinositol 3-Kinase/Protein Kinase B and Adenosine 5'-Monophosphate-Activated Protein Kinase Signaling Pathways Endocrinology, May 1, 2007; 148(5): 2016 - 2026. [Abstract] [Full Text] [PDF]

				K. M. Beard, H. Lu, K. Ho, and I. G. Fantus Bradykinin Augments Insulin-Stimulated Glucose Transport in Rat Adipocytes via Endothelial Nitric Oxide Synthase-Mediated Inhibition of Jun NH2-Terminal Kinase. Diabetes, October 1, 2006; 55(10): 2678 - 2687. [Abstract] [Full Text] [PDF]

				N. S Hopkinson, K. I Eleftheriou, J. Payne, A. H Nickol, E. Hawe, J. Moxham, H. Montgomery, and M. I Polkey +9/+9 Homozygosity of the bradykinin receptor gene polymorphism is associated with reduced fat-free mass in chronic obstructive pulmonary disease. Am. J. Clinical Nutrition, April 1, 2006; 83(4): 912 - 917. [Abstract] [Full Text] [PDF]

				C. Emanueli, M. B. Salis, A. Pinna, T. Stacca, A. F. Milia, A. Spano, J. Chao, L. Chao, L. Sciola, and P. Madeddu Prevention of Diabetes-Induced Microangiopathy by Human Tissue Kallikrein Gene Transfer Circulation, August 20, 2002; 106(8): 993 - 999. [Abstract] [Full Text] [PDF]

				C. L. Dumke, J. Kim, E. B. Arias, and G. D. Cartee Role of kallikrein-kininogen system in insulin-stimulated glucose transport after muscle contractions J Appl Physiol, February 1, 2002; 92(2): 657 - 664. [Abstract] [Full Text] [PDF]

				I. Duka, S. Shenouda, C. Johns, E. Kintsurashvili, I. Gavras, and H. Gavras Role of the B2 Receptor of Bradykinin in Insulin Sensitivity Hypertension, December 1, 2001; 38(6): 1355 - 1360. [Abstract] [Full Text] [PDF]

				T. Shiuchi, H. Nakagami, M. Iwai, Y. Takeda, T.-X. Cui, R. Chen, Y. Minokoshi, and M. Horiuchi Involvement of Bradykinin and Nitric Oxide in Leptin-Mediated Glucose Uptake in Skeletal Muscle Endocrinology, February 1, 2001; 142(2): 608 - 612. [Abstract] [Full Text] [PDF]

				A. Kudoh and A. Matsuki Effects of Angiotensin-Converting Enzyme Inhibitors on Glucose Uptake Hypertension, August 1, 2000; 36(2): 239 - 244. [Abstract] [Full Text] [PDF]

				P. d. O. Prada, M. M. Okamoto, L. N. S. Furukawa, U. F. Machado, J. C. Heimann, and M. S. Dolnikoff High- or Low-Salt Diet From Weaning to Adulthood : Effect on Insulin Sensitivity in Wistar Rats Hypertension, January 1, 2000; 35(1): 424 - 429. [Abstract] [Full Text] [PDF]

				E. J. Henriksen, S. Jacob, T. R. Kinnick, E. B. Youngblood, M. B. Schmit, and G. J. Dietze ACE inhibition and glucose transport in insulinresistant muscle: roles of bradykinin and nitric oxide Am J Physiol Regulatory Integrative Comp Physiol, July 1, 1999; 277(1): R332 - R336. [Abstract] [Full Text] [PDF]